Tapewire

NYSE · USD

CI

Cigna Group

Export transactions ↓
Tapewire entity
550
SEC CIK
0001739940
Parsed reports
653

Last 12 months

Inside the activity.

1 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 2026013
Jun 202601
Jul 202600
Aug 202602
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Jones Nicole SEVP, General Counsel
Tax withholdingCommon Stock, $.01 Par Value 2,183 $210.31 $459,106.73
Disclosure

SEC source: 0001225208-21-004364 · doc4.xml · nonDerivative · entry 3

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,655

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Jones Nicole SEVP, General Counsel
Tax withholdingCommon Stock, $.01 Par Value 1,227 $210.31 $258,050.37
Disclosure

SEC source: 0001225208-21-004364 · doc4.xml · nonDerivative · entry 2

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,838

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Jones Nicole SEVP, General Counsel
GrantCommon Stock, $.01 Par Value 4,710 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004364 · doc4.xml · nonDerivative · entry 1

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,065

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Evanko Brian CEVP, Chief Financial Officer
Tax withholdingCommon Stock, $.01 Par Value 644 $210.31 $135,439.64
Disclosure

SEC source: 0001225208-21-004363 · doc4.xml · nonDerivative · entry 3

Evanko Brian C · CIK 0001722909 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,428

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Evanko Brian CEVP, Chief Financial Officer
Tax withholdingCommon Stock, $.01 Par Value 601 $210.31 $126,396.31
Disclosure

SEC source: 0001225208-21-004363 · doc4.xml · nonDerivative · entry 2

Evanko Brian C · CIK 0001722909 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,072

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Evanko Brian CEVP, Chief Financial Officer
GrantCommon Stock, $.01 Par Value 2,053 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004363 · doc4.xml · nonDerivative · entry 1

Evanko Brian C · CIK 0001722909 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,673

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Manders Matthew GPres, Government and Solutions
Tax withholdingCommon Stock, $.01 Par Value 2,270 $210.31 $477,403.70
Disclosure

SEC source: 0001225208-21-004365 · doc4.xml · nonDerivative · entry 3

Manders Matthew G · CIK 0001480601 · Pres, Government and Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,656

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Manders Matthew GPres, Government and Solutions
Tax withholdingCommon Stock, $.01 Par Value 1,072 $210.31 $225,452.32
Disclosure

SEC source: 0001225208-21-004365 · doc4.xml · nonDerivative · entry 2

Manders Matthew G · CIK 0001480601 · Pres, Government and Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,926

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Manders Matthew GPres, Government and Solutions
GrantCommon Stock, $.01 Par Value 5,357 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004365 · doc4.xml · nonDerivative · entry 1

Manders Matthew G · CIK 0001480601 · Pres, Government and Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,998

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Neville EverettEVP, Strategy and Business Dev
Tax withholdingCommon Stock, $.01 Par Value 407 $210.31 $85,596.17
Disclosure

SEC source: 0001225208-21-004357 · doc4.xml · nonDerivative · entry 3

Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,581

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Neville EverettEVP, Strategy and Business Dev
Tax withholdingCommon Stock, $.01 Par Value 226 $210.31 $47,530.06
Disclosure

SEC source: 0001225208-21-004357 · doc4.xml · nonDerivative · entry 2

Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,988

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Neville EverettEVP, Strategy and Business Dev
GrantCommon Stock, $.01 Par Value 1,387 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004357 · doc4.xml · nonDerivative · entry 1

Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,214

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC Tax withholdingCommon Stock, $.01 Par Value 246 $210.31 $51,736.26
Disclosure

SEC source: 0001225208-21-004362 · doc4.xml · nonDerivative · entry 2

Eder Noelle K · CIK 0001691704 · EVP, CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,295

F2 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC GrantCommon Stock, $.01 Par Value 759 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004362 · doc4.xml · nonDerivative · entry 1

Eder Noelle K · CIK 0001691704 · EVP, CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,541

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Sadler Jason DPres., International Markets
GrantCommon Stock, $.01 Par Value 3,991 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004356 · doc4.xml · nonDerivative · entry 1

Sadler Jason D · CIK 0001554974 · Pres., International Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,028

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Cordani DavidDirector · President & CEO
Tax withholdingCommon Stock, $.01 Par Value 14,089 $210.31 $2,963,057.59
Disclosure

SEC source: 0001225208-21-004361 · doc4.xml · nonDerivative · entry 3

Cordani David · CIK 0001318751 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,544

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Cordani DavidDirector · President & CEO
Tax withholdingCommon Stock, $.01 Par Value 5,659 $210.31 $1,190,144.29
Disclosure

SEC source: 0001225208-21-004361 · doc4.xml · nonDerivative · entry 2

Cordani David · CIK 0001318751 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,633

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Cordani DavidDirector · President & CEO
GrantCommon Stock, $.01 Par Value 30,403 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004361 · doc4.xml · nonDerivative · entry 1

Cordani David · CIK 0001318751 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,292

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
Tax withholdingCommon Stock, $.01 Par Value 372 $210.31 $78,235.32
Disclosure

SEC source: 0001225208-21-004360 · doc4.xml · nonDerivative · entry 3

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,503

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
Tax withholdingCommon Stock, $.01 Par Value 151 $210.31 $31,756.81
Disclosure

SEC source: 0001225208-21-004360 · doc4.xml · nonDerivative · entry 2

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,875

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
GrantCommon Stock, $.01 Par Value 1,201 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004360 · doc4.xml · nonDerivative · entry 1

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,026

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
WENTWORTH TIMOTHY CCEO Evernorth
Tax withholdingCommon Stock, $.01 Par Value 8,016 $210.31 $1,685,844.96
Disclosure

SEC source: 0001225208-21-004359 · doc4.xml · nonDerivative · entry 4

WENTWORTH TIMOTHY C · CIK 0001252016 · CEO Evernorth

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,123

F4 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
WENTWORTH TIMOTHY CCEO Evernorth
Tax withholdingCommon Stock, $.01 Par Value 6,270 $209.90 $1,316,073.00
Disclosure

SEC source: 0001225208-21-004359 · doc4.xml · nonDerivative · entry 3

WENTWORTH TIMOTHY C · CIK 0001252016 · CEO Evernorth

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,139

F3 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
WENTWORTH TIMOTHY CCEO Evernorth
Tax withholdingCommon Stock, $.01 Par Value 2,727 $210.31 $573,515.37
Disclosure

SEC source: 0001225208-21-004359 · doc4.xml · nonDerivative · entry 2

WENTWORTH TIMOTHY C · CIK 0001252016 · CEO Evernorth

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,409

F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:27 UTC
WENTWORTH TIMOTHY CCEO Evernorth
GrantCommon Stock, $.01 Par Value 15,670 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004359 · doc4.xml · nonDerivative · entry 1

WENTWORTH TIMOTHY C · CIK 0001252016 · CEO Evernorth

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,136

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:30 UTC GrantPhantom Stock Units · Derivative 157 $209.90 $32,954.30
Disclosure

SEC source: 0001225208-21-004299 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,648

Underlying: Common Stock, $.01 Par Value · 157 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:30 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004299 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,606

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:30 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004298 · doc4.xml · nonDerivative · entry 1

ZARCONE DONNA F · CIK 0001243083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,019

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 91 of Cigna's proxy statement filed with the SEC on March 13, 2020.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC
FOSS ERIC JDirector
GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004290 · doc4.xml · nonDerivative · entry 1

FOSS ERIC J · CIK 0001197007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,362

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:30 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004291 · doc4.xml · nonDerivative · entry 1

Granger Elder · CIK 0001625579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,079

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004297 · doc4.xml · nonDerivative · entry 1

Ross Kimberly A. · CIK 0001536350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 960

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004295 · doc4.xml · nonDerivative · entry 1

PARTRIDGE JOHN · CIK 0001319897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,136

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004294 · doc4.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,557

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004293 · doc4.xml · nonDerivative · entry 1

MAZZARELLA KATHLEEN M · CIK 0001273233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,557

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC GrantCommon Stock, $.01 Par Value 226 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004289 · doc4.xml · nonDerivative · entry 1

DeLaney William J III · CIK 0001384151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,452

Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC
HARRIS ISAIAH JRDirector · Chairman of the Board
GrantCommon Stock, $.01 Par Value 273 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004292 · doc4.xml · nonDerivative · entry 1

HARRIS ISAIAH JR · CIK 0001202287 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,223

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 91 of Cigna's proxy statement filed with the SEC on March 13, 2020.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 20:22 UTC
MURABITO JOHN MEVP, HR & Services
GrantEmployee Stock Option (Right to Buy) · Derivative 12,150 $0.00 Strike: $213.80 $0.00
Disclosure

SEC source: 0001225208-21-003976 · doc4.xml · derivative · entry 3

MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,150

Underlying: Common Stock, $.01 Par Value · 12,150 shares

Expires 2031-02-24

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 26, 2021 20:22 UTC
MURABITO JOHN MEVP, HR & Services
GrantCommon Stock, $.01 Par Value 2,548 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-003976 · doc4.xml · nonDerivative · entry 1

MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,457

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:22 UTC
Lauria KristenEVP Chief Marketing Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 5,577 $0.00 Strike: $213.80 $0.00
Disclosure

SEC source: 0001225208-21-003973 · doc4.xml · derivative · entry 2

Lauria Kristen · CIK 0001808114 · EVP Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,577

Underlying: Common Stock, $.01 Par Value · 5,577 shares

Expires 2031-02-24

F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:22 UTC
Lauria KristenEVP Chief Marketing Officer
GrantCommon Stock, $.01 Par Value 1,170 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-003973 · doc4.xml · nonDerivative · entry 1

Lauria Kristen · CIK 0001808114 · EVP Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,485

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 2,789 $0.00 Strike: $213.80 $0.00
Disclosure

SEC source: 0001225208-21-003981 · doc4.xml · derivative · entry 3

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,789

Underlying: Common Stock, $.01 Par Value · 2,789 shares

Expires 2031-02-24

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
GrantCommon Stock, $.01 Par Value 585 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-003981 · doc4.xml · nonDerivative · entry 1

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,825

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Neville EverettEVP, Strategy and Business Dev
GrantEmployee Stock Option (Right to Buy) · Derivative 11,710 $0.00 Strike: $213.80 $0.00
Disclosure

SEC source: 0001225208-21-003980 · doc4.xml · derivative · entry 2

Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,710

Underlying: Common Stock, $.01 Par Value · 11,710 shares

Expires 2031-02-24

F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Neville EverettEVP, Strategy and Business Dev
GrantCommon Stock, $.01 Par Value 2,456 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-003980 · doc4.xml · nonDerivative · entry 1

Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,827

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Sadler Jason DPres., International Markets
GrantEmployee Stock Option (Right to Buy) · Derivative 12,184 $0.00 Strike: $213.80 $0.00
Disclosure

SEC source: 0001225208-21-003979 · doc4.xml · derivative · entry 2

Sadler Jason D · CIK 0001554974 · Pres., International Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,184

Underlying: Common Stock, $.01 Par Value · 12,184 shares

Expires 2031-02-24

F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Sadler Jason DPres., International Markets
GrantCommon Stock, $.01 Par Value 2,555 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-003979 · doc4.xml · nonDerivative · entry 1

Sadler Jason D · CIK 0001554974 · Pres., International Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,037

F1 · shares: These restricted stock units vest in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:22 UTC
Miller Steven BEVP, Chief Clinical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 6,134 $0.00 Strike: $213.80 $0.00
Disclosure

SEC source: 0001225208-21-003975 · doc4.xml · derivative · entry 2

Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,134

Underlying: Common Stock, $.01 Par Value · 6,134 shares

Expires 2031-02-24

F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:22 UTC
Miller Steven BEVP, Chief Clinical Officer
GrantCommon Stock, $.01 Par Value 1,287 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-003975 · doc4.xml · nonDerivative · entry 1

Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,546

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Triplett Michael WPresident, US Markets
GrantEmployee Stock Option (Right to Buy) · Derivative 12,826 $0.00 Strike: $213.80 $0.00
Disclosure

SEC source: 0001225208-21-003978 · doc4.xml · derivative · entry 3

Triplett Michael W · CIK 0001698840 · President, US Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,826

Underlying: Common Stock, $.01 Par Value · 12,826 shares

Expires 2031-02-24

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022.

Read SEC document
February 24, 2021 Filed Feb 27, 2021 01:23 UTC
Triplett Michael WPresident, US Markets
GrantCommon Stock, $.01 Par Value 2,690 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-003978 · doc4.xml · nonDerivative · entry 1

Triplett Michael W · CIK 0001698840 · President, US Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,376

F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.